Cyclophosphamide combined with glucocorticoid therapy is effective for improving the overall remission rate and can suppress inflammatory responses and oxidative stress in patients with idiopathic membranous nephropathy.
Keyphrases
- randomized controlled trial
- oxidative stress
- open label
- low dose
- high dose
- study protocol
- clinical trial
- dna damage
- rheumatoid arthritis
- cross sectional
- disease activity
- squamous cell carcinoma
- cell therapy
- systemic lupus erythematosus
- phase ii
- diabetic rats
- double blind
- ulcerative colitis
- endoplasmic reticulum stress
- heat shock protein